Importantly, we introduced FMD treatment that could improve the cellular uptake of nanoparticles and the immune effect to assist the therapy above to form a combination therapy of “PD-1/PD-L1 ICI + PDT + FMD”, thereby further inhibiting the development of the 4T1 tumor. Here, PDCD1 is linked to neoplasm.